Page last updated: 2024-08-25

artemether and Osteolysis

artemether has been researched along with Osteolysis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hu, B; Meng, J; Shi, Z; Wu, H; Yan, S; Yang, Y; Zhao, X; Zhou, C; Zhou, X	1

Other Studies

1 other study(ies) available for artemether and Osteolysis

Article	Year
Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway. Cell death & disease, 2018, 05-01, Volume: 9, Issue:5 Topics: Animals; Artemether; Bone Density Conservation Agents; Bone Remodeling; Disease Models, Animal; Gene Expression Regulation; Lipopolysaccharides; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Osteoclasts; Osteogenesis; Osteolysis; RANK Ligand; RAW 264.7 Cells	2018

Article

Year

Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway.

Cell death & disease, 2018, 05-01, Volume: 9, Issue:5

Topics: Animals; Artemether; Bone Density Conservation Agents; Bone Remodeling; Disease Models, Animal; Gene Expression Regulation; Lipopolysaccharides; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Osteoclasts; Osteogenesis; Osteolysis; RANK Ligand; RAW 264.7 Cells

2018